miR-222 regulates proliferation of primary mouse hepatocytes in vitro.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
09 04 2019
Historique:
received: 13 02 2019
accepted: 17 02 2019
pubmed: 4 3 2019
medline: 22 1 2020
entrez: 4 3 2019
Statut: ppublish

Résumé

It is well known that hepatocytes regenerate after liver injury, although it is difficult to reproduce this phenomenon in vitro. The goal of this research was to determine the factors that stimulate proliferation of primary mouse hepatocytes (PMHs) in vitro. We first tested knockdown (KD) of tumor protein 53 (p53) alone as well as partial hepatectomy (PH, performed 72 h prior to PMHs preparation) alone. However, neither intervention stimulated hepatocyte proliferation during the 72-h observation period in vitro. We then tested the combination of p53 KD with PH and found that these interventions together stimulated cell proliferation in vitro. Under these latter conditions we analyzed gene expression of these cells by mRNA sequencing (RNA-seq) and microRNA sequencing (miRNA-seq). TargetScan analysis, which determines the relationship between microRNAs and gene expression, found a relationship between downregulated mmu-mir-222 (miR-222) and upregulated genes such as mitogen-activated protein kinase kinase kinase 2 (Map3k2). To confirm this relationship, we performed miR-222 KD and overexpression (OE) and observed the expected changes in target gene expression. Furthermore, the finding that miR-222 KD or OE stimulates or suppresses, respectively, hepatocyte proliferation is well explained by the association between miR-222 and its target genes, which stimulate growth. Our results suggest that miR-222 is one of the key factors regulating PMH proliferation in vitro.

Identifiants

pubmed: 30826054
pii: S0006-291X(19)30289-X
doi: 10.1016/j.bbrc.2019.02.093
pii:
doi:

Substances chimiques

MIRN222 microRNA, mouse 0
MicroRNAs 0
MAP Kinase Kinase Kinase 2 EC 2.7.11.25
Map3k2 protein, mouse EC 2.7.11.25

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

644-649

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Miki Higashi (M)

Department of Biochemistry, Nagasaki University School of Medicine, Nagasaki, Japan; Department of Physiology, Saitama Medical University, Saitama, Japan.

Mitsuhiro Yoneda (M)

Department of Biochemistry, Nagasaki University School of Medicine, Nagasaki, Japan.

Takeya Nakagawa (T)

Department of Biochemistry, Nagasaki University School of Medicine, Nagasaki, Japan.

Masaaki Ikeda (M)

Department of Physiology, Saitama Medical University, Saitama, Japan.

Takashi Ito (T)

Department of Biochemistry, Nagasaki University School of Medicine, Nagasaki, Japan. Electronic address: tito@nagasaki-u.ac.jp.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH